Vital Farms’s (NASDAQ:VITL) Q3 2026 earnings results: revenue in line with expectations but stock drops 10.4%
Vital Farms (VITL) reported Q3 2026 revenue of $182.2M, matching estimates but down 8.4% YoY. EPS missed at -$0.15 vs -$0.12 expected. Adjusted EBITDA was $1.5M, slightly below estimates. The company lowered full-year revenue guidance to $730M from $787.5M, with EBITDA guidance of -$15M, below expectations. Operating margin fell to -4.2% from 10.8% YoY, and free cash flow was -$22.79M.
How this was made
The 30-second read
Why it matters
The combination of an EPS miss, weaker operating margin, worse free cash flow, and lowered FY revenue and EBITDA guidance is a clear negative catalyst for valuation and near-term expectations.
Market read
Traders can use the guidance midpoint cuts to update FY revenue and profitability expectations immediately after the earnings release.
What to watch
Free cash flow deterioration and operating margin decline could reflect working-capital swings; traders may wait for commentary on the drivers before extrapolating a sustained earnings reset.
Background
The piece reports Vital Farms Q3 2026 results and, crucially, a full-year guidance reduction for both revenue and EBITDA.
Ticker impact
Vital Farms reported Q3 revenue of $182.2M in line, but lowered full-year revenue guidance to $730M and EBITDA guidance to -$15M at the midpoint.
Likely further pressure or elevated volatility as the market digests the full-year guidance reduction versus prior expectations.
The article discloses multiple guidance downgrades (revenue and EBITDA) alongside a GAAP EPS miss and worsening operating margin, which typically outweigh an in-line revenue print.
Market effects
Signals continued margin and cash-flow pressure for packaged food and specialty agriculture brands, potentially raising scrutiny on profitability discipline.
Limited direct regional spillover; primarily company-specific repricing.
Low global relevance; impacts are likely confined to US-listed consumer/food supply-chain sentiment.
Counterpoint
Investors may focus on revenue being in line and treat EBITDA and cash-flow weakness as temporary execution or cost timing rather than a structural demand problem.
Key entities
- companyVital Farms
NASDAQ-listed specialty food company reporting Q3 results and cutting full-year revenue and EBITDA guidance.
